Reagents and materials
Digoxigenin, BSA (bovine serum albumin), human serum, Tween-20, EDC (N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride), Sulfo-NHS (sulfosuccinimidyl 4,4′-azipentanoate), BIS-TRIS hydrochloride (2,2-Bis(hydroxymethyl)-2,2′,2″-nitrilotriethanol), sodium chloride, Triton X-100, HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and Pur-A-Lyzer-Midi (6000-8000MWCO) were purchased from Sigma Aldrich (https://www.sigmaaldrich.com). PBS (Phosphate buffered saline 10×) was purchased from AppliChem (https://www.itwreagents.com). α-digoxigenin-monoclonal-antibodies were purchased from Roche (https://lifescience.roche.com). Spherical gold nanoparticles, 50 nm Lipoic Acid NanoXact Gold, were purchased from nanoComposix (https://nanocomposix.eu/). Lateral-Flow-Assay strips for the LFA were provided by R-Biopharm (https://r-biopharm.com/de). The test line (tl) consists of a digoxigenin-BSA-conjugate. The control line (cl) consists of anti-mouse-polyclonal antibody. Test and control lines are 5 mm apart. The membrane material is nitrocellulose with 0.5 μm pore size. Buffers and reagents were prepared in milli-Q water (18.2 MΩ·cm).
Immunoprobe composition and synthesis
Synthesis of spherical gold bioprobes
A 1 μL quantity of a freshly prepared EDC/sulfo-NHS solution (c = 5.5 mmol·L−1 in milliQ water, 100.000-fold molar excess) was added to 1 ml of 50 nm Lipoic Acid NanoXact Gold particles (c = 56.5 pmol) and incubated at 250 rpm, 7 °C for 30 min in the dark. A dialysis tube (MWCO 6000-8000 kDa) was used to remove excess of EDC/sulfo-NHS. The mixture was dialyzed against 800 ml HEPES-buffer (20 mM 0.1% Tween 20 pH 7.2) for 90 min, at room temperature (RT), in the dark. Then, a 120-fold excess of Digoxigenin-antibody (1 μL c = 6.6 μmol·L−1) was added. The reaction mix was incubated for 2 h, 250 rpm, 7 °C in the dark. Then, 10% BSA-solution in HEPES was added to a final content of 1%. The volume of AuNP-conjugate solution was adjusted to a final volume of 1.5 mL with 1% BSA in HEPES. Conjugates obtained can be stored at 4 °C in the dark for several weeks.
LFA assay procedure, samples and reagents
Digoxigenin stock solutions for calibration with concentrations of 0,1,20,40,60,80,100 nmol·L−1 were prepared in PBS (pH 7.4, 0.01 M; 0.001 M EDTA). Every calibration solution was measured in five repetitions. Digoxigenin samples in human serum were prepared at concentrations of 0, 1, 5, 10, 15, 20, 25, 30, 40, 60, 80, 100 nmol·L−1 (three repetitions). The running buffer (RB) contained 0.05 M BIS-TRIS, 8% Triton X-100, 0.3% BSA.
A 10 μL sample (digoxigenin calibration solution or serum sample), 45 μL of running buffer, and 15 μL of conjugate solution were mixed in a 2 mL flat bottom reaction vessel; 30 s after mixing, the components the Digoxigenin LFA-strip were placed in the sample mix. The runtime for the 70 μL sample mix was 5 min. The test-strips were then placed on a flat surface and allowed to dry for 10 min. LFA-strips then were then ready for readout through the iPhone 5S or BioImager (ChemStudio Plus, Analytic Jena).
LFA assay principle and format
A direct competitive digoxigenin-LFA assay based on colorimetric bioprobes (gold nanoparticle-antibody-conjugates) was used in the detection method. Digoxigenin calibration solutions or spiked samples in human serum and antibody conjugates were mixed and applied on the LFA-membranes. Bioprobes without bound digoxigenin were bound to the test line. Otherwise, if digoxigenin was bound to the conjugated antibodies on the nanoparticle surface, the probes migrated further to the control line, where anti-mouse secondary antibodies bound to the mouse primary antibodies from the bioprobes. The colored bands on the test/control lines are photographed (in our case, using a CMOS smartphone camera from the iPhone 5S and a cardboard darkbox or BioImager (ChemStudio Plus with a 16MP CCD camera).
The colorimetric signal on the test-line is inversely related to the digoxigenin concentration in the samples. With the control-line as a calibration standard, signals can be normalized and calibrated for different readout devices using the same statistical methods (see: Data acquisition and processing) (Fig. 3).
GNSplex: an R-package for analysis of the data of gold nanoparticle-based bioassay
GNSplex is an open-source package completely developed in the statistical software R [10]. It is mainly based on the bioconductor package EBImage as well as R-packages ggplot2 and ggpmisc [10,11,12,13]. GNSplex utilizes the implemented functionalities of EBImage to process jpeg images from lateral flow strips cut to a specific size. Images must include the test and control line to obtain an appropriate signal. We provide templates of the jpeg files in the folder exData of our package GNSplex. GNSplex uses the R-packages ggplot2 and ggpmisc to generate plots of the fitted linear models [10, 13]. The sources of GNSplex are available for download from https://github.com/NPhogat/GNSplex and can be installed in R using the package devtools [14, 15]. The package also includes an in-built Shiny app and a standalone graphical user interface (GUI) to make the analysis of the image data more user-friendly. In addition, the Shiny app can be used to generate an analysis report of the results via the R-package rmarkdown [16, 17]. BioImager and iPhone images of samples at different concentrations of digoxigenin calibration standards and spiked human serum samples were taken. The intensities of the test line (tl) and control line (cl) were extracted, the background was corrected and the normalized intensities (cl/tl) were computed. Linear models based on the normalized intensities (cl/tl) and the concentrations (nM) were used. To increase the functionality of our package, it is possible to fit simple linear models based on the standardized intensities (tl/cl) and the concentrations (nM). The package furthermore includes functions also incorporated into the GUI to compute the standard deviation (SD) within replicates of the raw intensities of the control and test line, as well as of normalized and standardized intensities, confidence intervals of normalized and standardized intensities and the Pearson correlation of the normalized and standardized intensities with respect to their predicted values. Further, the package can be used to compute the limit of detection (LOD) and limit of quantification (LOQ) statistically, based on two different methods. The first method to compute the LOD and LOQ is based on the following formulas:
$$ {\displaystyle \begin{array}{l}\mathrm{LOD}=\mathrm{Mean}\ \mathrm{of}\ \mathrm{blank}\ \mathrm{data}+{3}^{\ast}\left(\mathrm{standard}\ \mathrm{deviation}\ \mathrm{of}\ \mathrm{blank}\ \mathrm{data}\right)\\ {}\mathrm{LOQ}=\mathrm{Mean}\ \mathrm{of}\ \mathrm{blank}\ \mathrm{data}+{10}^{\ast}\left(\mathrm{standard}\ \mathrm{deviation}\ \mathrm{of}\ \mathrm{blank}\ \mathrm{data}\right)\end{array}} $$
The formulas for the second method to compute the limit of blank (LOB), LOD and LOQ read:
$$ {\displaystyle \begin{array}{l}\mathrm{LOB}=\mathrm{Mean}\ \mathrm{of}\ \mathrm{the}\ \mathrm{blank}\ \mathrm{data}+{1.645}^{\ast}\left(\mathrm{standard}\ \mathrm{deviation}\ \mathrm{of}\ \mathrm{blank}\ \mathrm{data}\right)\\ {}\mathrm{LOD}=\mathrm{LOB}+{1.645}^{\ast}\left(\mathrm{standard}\ \mathrm{deviation}\ \mathrm{of}\ 1\mathrm{nM}\ \mathrm{sample}\ \mathrm{data}\right)\\ {}\mathrm{LOQ}=\mathrm{Mean}\ \mathrm{of}\ \mathrm{blank}\ \mathrm{data}+{10}^{\ast}\left(\mathrm{standard}\ \mathrm{deviation}\ \mathrm{of}\ \mathrm{blank}\ \mathrm{data}\right)\end{array}} $$
The respective results for standardized intensities are shown in the supplementary information.